中国人群中2型糖尿病亚型的鉴定及其独特的并发症风险概况

IF 5.7 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Qiu Xiao, Chengjun Zhang, Yanfeng Jiang, Chen Suo, Genming Zhao, Xingdong Chen, Min Chen, Kelin Xu
{"title":"中国人群中2型糖尿病亚型的鉴定及其独特的并发症风险概况","authors":"Qiu Xiao, Chengjun Zhang, Yanfeng Jiang, Chen Suo, Genming Zhao, Xingdong Chen, Min Chen, Kelin Xu","doi":"10.1111/dom.70056","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>To identify and validate subgroups of type 2 diabetes in Chinese populations using clustering analysis and assess their complication risks.</p><p><strong>Materials and methods: </strong>Data from 5653 type 2 diabetes patients in the Shanghai Suburban Adult Cohort and Biobank (SSACB) and 6384 in the Southwest China Diabetic Chronic Complications Study were integrated. Using body mass index, fasting blood glucose, age at diabetes diagnosis, and triglycerides to high-density lipoprotein cholesterol ratio, k-means clustering was performed by sex in SSACB and validated in Southwest China Diabetic Chronic Complications Study. Cox and logistic regression models compared complication risks.</p><p><strong>Results: </strong>Five type 2 diabetes subgroups were identified: Hyperglycaemic Diabetes (HGD), Obesity-Related Diabetes (ORD), Young-Onset Diabetes (YOD), Insulin Resistance Diabetes (IRD), and Elderly-Onset Diabetes (EOD). Verification in an external validation cohort confirmed the robustness and reproducibility of the identified subgroups. In SSACB, distinct subgroup-specific complication risks were observed. Specifically, the HGD subgroup showed the highest risks for stroke (HR = 1.37, 95% CI: 1.10-1.70), peripheral vascular disease (HR = 1.66, 95% CI: 1.36-2.03), retinopathy (HR = 3.53, 95% CI: 2.53-4.90), peripheral neuropathy (HR = 1.89, 95% CI: 1.56-2.30), and nephropathy (HR = 1.81, 95% CI: 1.41-2.34). The IRD subgroup had the highest risk for coronary heart disease (HR = 1.20, 95% CI: 1.01-1.43). Similar risk patterns were observed in the validation cohort.</p><p><strong>Conclusions: </strong>We identified five clinically distinct type 2 diabetes subgroups with differential complication risks in the Chinese population, providing a basis for precision diabetes management.</p>","PeriodicalId":158,"journal":{"name":"Diabetes, Obesity & Metabolism","volume":" ","pages":""},"PeriodicalIF":5.7000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles.\",\"authors\":\"Qiu Xiao, Chengjun Zhang, Yanfeng Jiang, Chen Suo, Genming Zhao, Xingdong Chen, Min Chen, Kelin Xu\",\"doi\":\"10.1111/dom.70056\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>To identify and validate subgroups of type 2 diabetes in Chinese populations using clustering analysis and assess their complication risks.</p><p><strong>Materials and methods: </strong>Data from 5653 type 2 diabetes patients in the Shanghai Suburban Adult Cohort and Biobank (SSACB) and 6384 in the Southwest China Diabetic Chronic Complications Study were integrated. Using body mass index, fasting blood glucose, age at diabetes diagnosis, and triglycerides to high-density lipoprotein cholesterol ratio, k-means clustering was performed by sex in SSACB and validated in Southwest China Diabetic Chronic Complications Study. Cox and logistic regression models compared complication risks.</p><p><strong>Results: </strong>Five type 2 diabetes subgroups were identified: Hyperglycaemic Diabetes (HGD), Obesity-Related Diabetes (ORD), Young-Onset Diabetes (YOD), Insulin Resistance Diabetes (IRD), and Elderly-Onset Diabetes (EOD). Verification in an external validation cohort confirmed the robustness and reproducibility of the identified subgroups. In SSACB, distinct subgroup-specific complication risks were observed. Specifically, the HGD subgroup showed the highest risks for stroke (HR = 1.37, 95% CI: 1.10-1.70), peripheral vascular disease (HR = 1.66, 95% CI: 1.36-2.03), retinopathy (HR = 3.53, 95% CI: 2.53-4.90), peripheral neuropathy (HR = 1.89, 95% CI: 1.56-2.30), and nephropathy (HR = 1.81, 95% CI: 1.41-2.34). The IRD subgroup had the highest risk for coronary heart disease (HR = 1.20, 95% CI: 1.01-1.43). Similar risk patterns were observed in the validation cohort.</p><p><strong>Conclusions: </strong>We identified five clinically distinct type 2 diabetes subgroups with differential complication risks in the Chinese population, providing a basis for precision diabetes management.</p>\",\"PeriodicalId\":158,\"journal\":{\"name\":\"Diabetes, Obesity & Metabolism\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":5.7000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes, Obesity & Metabolism\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/dom.70056\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Obesity & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dom.70056","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

目的:通过聚类分析确定和验证中国人群中2型糖尿病亚群,并评估其并发症风险。材料和方法:将上海郊区成人队列和生物库(SSACB)的5653例2型糖尿病患者和中国西南糖尿病慢性并发症研究的6384例患者的数据进行整合。采用体重指数、空腹血糖、糖尿病诊断年龄、甘油三酯与高密度脂蛋白胆固醇比值,在SSACB中按性别进行k-means聚类,并在中国西南地区糖尿病慢性并发症研究中得到验证。Cox和logistic回归模型比较并发症风险。结果:确定了5个2型糖尿病亚组:高血糖型糖尿病(HGD)、肥胖相关糖尿病(ORD)、年轻型糖尿病(YOD)、胰岛素抵抗型糖尿病(IRD)和老年型糖尿病(EOD)。外部验证队列的验证证实了确定的亚组的稳健性和可重复性。在SSACB中,观察到明显的亚组特异性并发症风险。具体来说,HGD亚组中风(HR = 1.37, 95% CI: 1.10-1.70)、外周血管疾病(HR = 1.66, 95% CI: 1.36-2.03)、视网膜病变(HR = 3.53, 95% CI: 2.53-4.90)、外周神经病变(HR = 1.89, 95% CI: 1.56-2.30)和肾病(HR = 1.81, 95% CI: 1.41-2.34)的风险最高。IRD亚组发生冠心病的风险最高(HR = 1.20, 95% CI: 1.01-1.43)。在验证队列中也观察到类似的风险模式。结论:我们在中国人群中确定了5个临床不同的2型糖尿病亚组,它们具有不同的并发症风险,为糖尿病的精确管理提供了基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles.

Aims: To identify and validate subgroups of type 2 diabetes in Chinese populations using clustering analysis and assess their complication risks.

Materials and methods: Data from 5653 type 2 diabetes patients in the Shanghai Suburban Adult Cohort and Biobank (SSACB) and 6384 in the Southwest China Diabetic Chronic Complications Study were integrated. Using body mass index, fasting blood glucose, age at diabetes diagnosis, and triglycerides to high-density lipoprotein cholesterol ratio, k-means clustering was performed by sex in SSACB and validated in Southwest China Diabetic Chronic Complications Study. Cox and logistic regression models compared complication risks.

Results: Five type 2 diabetes subgroups were identified: Hyperglycaemic Diabetes (HGD), Obesity-Related Diabetes (ORD), Young-Onset Diabetes (YOD), Insulin Resistance Diabetes (IRD), and Elderly-Onset Diabetes (EOD). Verification in an external validation cohort confirmed the robustness and reproducibility of the identified subgroups. In SSACB, distinct subgroup-specific complication risks were observed. Specifically, the HGD subgroup showed the highest risks for stroke (HR = 1.37, 95% CI: 1.10-1.70), peripheral vascular disease (HR = 1.66, 95% CI: 1.36-2.03), retinopathy (HR = 3.53, 95% CI: 2.53-4.90), peripheral neuropathy (HR = 1.89, 95% CI: 1.56-2.30), and nephropathy (HR = 1.81, 95% CI: 1.41-2.34). The IRD subgroup had the highest risk for coronary heart disease (HR = 1.20, 95% CI: 1.01-1.43). Similar risk patterns were observed in the validation cohort.

Conclusions: We identified five clinically distinct type 2 diabetes subgroups with differential complication risks in the Chinese population, providing a basis for precision diabetes management.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Diabetes, Obesity & Metabolism
Diabetes, Obesity & Metabolism 医学-内分泌学与代谢
CiteScore
10.90
自引率
6.90%
发文量
319
审稿时长
3-8 weeks
期刊介绍: Diabetes, Obesity and Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. ‘Metabolism’ may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信